L. Dawson

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial

Susan Richman, Phil Quirke, Gary Middleton, 2013, The Lancet. Oncology.

Addition of panitumumab to irinotecan: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC).

T. Hickish, S. Gwyther, P. Quirke, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?

M. Fallon, H. Phillips, L. Wall, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weekly.

J. Smyth, D. Jodrell, A. Bernareggi, 2000, European journal of cancer.

Bacterial endocarditis associated with a skin-tunnelled catheter.

R. Leonard, L. Dawson, 1999, Breast.

High dose therapy of breast cancer: current status.

R. Leonard, L. Dawson, 1999, Critical reviews in oncology/hematology.

Osteonecrosis of the femoral head following adjuvant chemotherapy for breast cancer.

F. Nussey, R. Leonard, T. Oliver, 2001, Breast.

Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial

V. Khoo, A. Gentry-Maharaj, C. Patrono, 2023, British Journal of Cancer.